HomeComparePBIO vs SPHD

PBIO vs SPHD: Dividend Comparison 2026

PBIO yields 166666.67% · SPHD yields 4.33%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PBIO wins by $11911377672882.59M in total portfolio value
10 years
PBIO
PBIO
● Live price
166666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11911377672882.62M
Annual income
$5,393,136,696,480,418,000.00
Full PBIO calculator →
SPHD
SPHD
● Live price
4.33%
Share price
$49.34
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$571.32
Full SPHD calculator →

Portfolio growth — PBIO vs SPHD

📍 PBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPBIOSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PBIO + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PBIO pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBIO
Annual income on $10K today (after 15% tax)
$14,166,666.67/yr
After 10yr DRIP, annual income (after tax)
$4,584,166,192,008,355,000.00/yr
SPHD
Annual income on $10K today (after 15% tax)
$367.92/yr
After 10yr DRIP, annual income (after tax)
$485.62/yr
At 15% tax rate, PBIO beats the other by $4,584,166,192,008,354,300.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBIO + SPHD for your $10,000?

PBIO: 50%SPHD: 50%
100% SPHD50/50100% PBIO
Portfolio after 10yr
$5955688836441.32M
Annual income
$2,696,568,348,240,209,400.00/yr
Blended yield
45.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PBIO right now

PBIO
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-50.4
Piotroski
2/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBIO buys
0
SPHD buys
0
No recent congressional trades found for PBIO or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPBIOSPHD
Forward yield166666.67%4.33%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$11911377672882.62M$26.5K
Annual income after 10y$5,393,136,696,480,418,000.00$571.32
Total dividends collected$11310008644767.18M$5.1K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: PBIO vs SPHD ($10,000, DRIP)

YearPBIO PortfolioPBIO Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$8,344,033$8,333,333.33$11,133$432.85+$8.33MPBIO
2$3,258,162,280$3,249,234,164.07$12,363$450.36+$3258.15MPBIO
3$596,362,299,915$592,876,066,275.31$13,695$467.39+$596362.29MPBIO
4$51,347,407,585,706$50,709,299,924,797.41$15,138$483.90+$51347407.57MPBIO
5$2,095,186,069,772,327$2,040,244,343,655,621.00$16,697$499.88+$2095186069.76MPBIO
6$41,143,898,865,343,200$38,902,049,770,686,810.00$18,382$515.31+$41143898865.32MPBIO
7$401,002,058,588,188,860$356,978,086,802,271,700.00$20,198$530.17+$401002058588.17MPBIO
8$2,054,879,028,737,436,700$1,625,806,826,048,074,500.00$22,157$544.46+$2054879028737.41MPBIO
9$6,091,813,996,637,570,000$3,893,093,435,888,512,500.00$24,266$558.18+$6091813996637.55MPBIO
10$11,911,377,672,882,618,000$5,393,136,696,480,418,000.00$26,536$571.32+$11911377672882.59MPBIO

PBIO vs SPHD: Complete Analysis 2026

PBIOStock

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp.

Full PBIO Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this PBIO vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBIO vs SCHDPBIO vs JEPIPBIO vs OPBIO vs KOPBIO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.